Both in Pharmaceuticals
Wave Life Sciences vs Kura Oncology
Over the past year WVE returned −55.7% and KURA returned −16.8%; their daily moves had a correlation of 0.15.
WVE −55.7% KURA −16.8%Growth of $1, one year, split-adjusted
| Metric | WVE | KURA |
|---|---|---|
| Price | $3.68 | $8.13 |
| Market cap | $725.8M | $723.2M |
| Today | +2.79% | −17.71% |
| 1 month | +4.5% | −22.8% |
| 6 months | −49.5% | −15.0% |
| Year to date | −78.4% | −21.8% |
| 1 year | −55.7% | −16.8% |
| Revenue growth (YoY) | +72.9% | +36.5% |
| Gross margin | 100.0% | 98.8% |
| Net margin | −470.5% | −327.3% |
| P/E (TTM) | — | — |
| Price / sales | 10.2× | 9.4× |
| Net cash | $430.7M | $509.2M |
| Dividend yield | — | — |
| Volatility (60d) | 51.7% | 68.4% |
| Short % of float | 17.0% | 18.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).